Fucoidan as a Potential Therapeutic for Major Blinding Diseases--A Hypothesis
about
Oligo-Fucoidan prevents IL-6 and CCL2 production and cooperates with p53 to suppress ATM signaling and tumor progression.Combination Treatment of Deep Sea Water and Fucoidan Attenuates High Glucose-Induced Insulin-Resistance in HepG2 Hepatocytes.Functional genomics analysis reveals the biosynthesis pathways of important cellular components (alginate and fucoidan) of Saccharina.
P2860
Fucoidan as a Potential Therapeutic for Major Blinding Diseases--A Hypothesis
description
2016 nî lūn-bûn
@nan
2016 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Fucoidan as a Potential Therapeutic for Major Blinding Diseases--A Hypothesis
@ast
Fucoidan as a Potential Therapeutic for Major Blinding Diseases--A Hypothesis
@en
Fucoidan as a Potential Therapeutic for Major Blinding Diseases--A Hypothesis
@nl
type
label
Fucoidan as a Potential Therapeutic for Major Blinding Diseases--A Hypothesis
@ast
Fucoidan as a Potential Therapeutic for Major Blinding Diseases--A Hypothesis
@en
Fucoidan as a Potential Therapeutic for Major Blinding Diseases--A Hypothesis
@nl
prefLabel
Fucoidan as a Potential Therapeutic for Major Blinding Diseases--A Hypothesis
@ast
Fucoidan as a Potential Therapeutic for Major Blinding Diseases--A Hypothesis
@en
Fucoidan as a Potential Therapeutic for Major Blinding Diseases--A Hypothesis
@nl
P2860
P921
P356
P1433
P1476
Fucoidan as a Potential Therapeutic for Major Blinding Diseases--A Hypothesis
@en
P2093
Alexa Klettner
P2860
P356
10.3390/MD14020031
P407
P5008
P577
2016-02-01T00:00:00Z
2016-02-03T00:00:00Z